SIHUAN PHARMACE (TEL1.SG)

SIHUAN PHARMACE (TEL1.SG)

TEL1 · STU · Other / Other

0.073EUR-0.00 (-0.68%)

Price History

Full chart

Market Stats

Previous Close0.0735
Open0.07
Day Range0.07 – 0.076
52-Week Range0.0675 – 0.1776
Volume0
Market Cap1.66B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield35.00%
50-Day Avg0.0813
200-Day Avg0.1164

About

There is no Profile data available for TEL1.SG.

Company Details

  • SectorOther
  • IndustryOther
  • Employees0
  • HeadquartersGermany

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.19B2.75B2.92B2.89B2.46B3.04B2.18B1.86B1.90B2.62B
Growth (%)--13.81%+6.25%-1.04%-14.64%+23.30%-28.21%-14.70%+2.18%+37.71%
Cost of Revenue996.75M758.96M538.32M592.05M549.78M607.90M693.61M564.89M659.40M816.15M
Gross Profit2.19B1.99B2.38B2.29B1.91B2.43B1.49B1.30B1.24B1.80B
Gross Margin68.71%72.36%81.55%79.49%77.69%79.99%68.20%69.64%65.32%68.83%
Operating Expense341.18M569.86M708.47M992.73M1.47B1.78B2.04B1.49B1.70B1.43B
Operating Income1.85B1.42B1.67B1.30B448.87M647.68M-554.21M-191.49M-461.89M375.09M
Operating Margin58.00%51.61%57.26%45.11%18.22%21.32%-25.41%-10.29%-24.30%14.33%
EBITDA-2.03B2.33B-2.11B1.05B914.73M-1.54B334.31M105.07M844.02M
EBITDA Margin-73.79%79.71%-73.00%42.70%30.11%-70.69%17.97%5.53%32.24%
Net Income1.71B1.45B1.62B-2.75B473.38M416.51M-1.91B-54.02M-216.66M179.70M
Net Income Margin53.62%52.77%55.53%-95.37%19.21%13.71%-87.79%-2.90%-11.40%6.86%
R&D--480.32M632.97M729.16M868.07M936.58M577.66M473.93M291.27M
R&D as % of Total Revenue--16.46%21.93%29.59%28.57%42.94%31.05%24.93%11.13%
Interest Expense006.06M4.87M8.22M117.35M211.18M269.34M274.93M201.57M
Interest Expense % of Total Revenue0.00%0.00%0.21%0.17%0.33%3.86%9.68%14.48%14.46%7.70%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets12.19B13.59B15.44B12.57B13.04B14.50B12.14B11.54B10.53B11.63B
Total Liabilities1.22B2.26B2.67B2.63B3.10B5.35B6.50B6.40B5.58B4.73B
Total Equity10.90B11.06B12.51B9.61B9.19B8.28B4.74B4.43B4.37B5.85B
Cash2.41B831.86M3.31B5.12B4.60B5.68B4.01B3.78B3.52B3.56B

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.02B1.92B1.79B1.42B227.13M665.29M46.49M199.49M276.14M-23.56M
Capital Expenditure364.59M487.03M389.45M645.56M580.61M767.43M593.94M295.42M186.38M194.50M
Free Cash Flow-1.43B1.40B772.29M-353.48M-102.14M-547.44M-95.93M89.77M-218.06M
Dividends Paid607.06M1.14B240.01M198.81M1.44B122.89M1.32B298.56M177.08M90.89M
FCF to OCF-74.60%78.28%54.47%-155.63%-15.35%-1177.48%-48.09%32.51%925.52%
Dividend Paid to FCF-79.98%17.10%25.74%-408.61%-120.32%-240.30%-311.22%197.27%-41.68%

Earnings

Report DateMar 30, 2027
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap1.66B
Enterprise Value427.90M
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales1.99
Price / Book0.86
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding0
Shares Float0
Dividend Yield35.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
0.00Jun 30, 2026
20251×
0.00Sep 26, 2025
20241×
0.00Sep 27, 2024
20231×
0.00Jun 6, 2023
20222×
0.00Sep 30, 20220.01May 26, 2022
20212×
0.00Jul 5, 20210.02Jul 2, 2021
20202×
0.00Sep 29, 20200.01Jun 18, 2020
20192×
0.00Oct 17, 20190.00Jun 5, 2019
20182×
0.00Oct 18, 20180.00Jun 7, 2018
20172×
0.00Sep 1, 20170.01Jun 22, 2017
20162×
0.00Sep 5, 20160.01Jun 30, 2016
20152×
0.00Dec 17, 20150.00Sep 11, 2015
20142×
0.00Sep 10, 20140.00Jun 5, 2014
20132×
0.00Sep 6, 20130.00Jun 4, 2013

Stock Splits

  • Jun 5, 20142:1